By Leroy Leo and Khushi Mandowara (Reuters) - Medical device companies and some drugmakers with manufacturing operations in Puerto Rico said they do not expect meaningful...
By Jessica DiNapoli NEW YORK (Reuters) - Nestle SA (SIX:NESN)'s Gerber Products Company is still in "critical task force mode" due to the U.S. infant formula shortage, its CEO...
By Alexandra Alper and Mrinalika Roy (Reuters) -The Biden administration will extend through year end waivers that make it easier for low-income families to access baby formula...
What Did We Learn From Trade Desk’s Q2 Report? Digital advertising leader The Trade Desk (NASDAQ:TTD) matched Wall Street’s EPS forecast of $0.20 but breezed past its...
Diversification is the edge for any portfolio. Rising inflation is impacting discretionary consumer spending. These stocks tend to be good recession hedges by either thriving in a...
Many growth stocks and exchange-traded funds (ETFs) are currently changing hands around 52-week or even multi-year lows and the impending earnings season could bring more...
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
| Average | 124.89 (+29.07% Upside) |
| High | 150 |
| Low | 95 |
| Price | 96.76 |
| No. of Analysts | 24 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.62 | 7.78 | 7.17 | +0.37 | +5.10% | 8.42M | NYSE | |||
| 18.41 | 18.55 | 18.10 | +0.33 | +1.83% | 6.29M | NYSE | |||
| 265.25 | 275.57 | 262.47 | -2.96 | -1.10% | 66.83M | NASDAQ | |||
| 126.25 | 129.04 | 126.21 | -2.45 | -1.90% | 9.39M | NYSE | |||
| 34.63 | 34.94 | 34.45 | -0.40 | -1.14% | 47.17K | OTC Markets | |||
| 16.73 | 17.25 | 16.14 | -0.20 | -1.18% | 6.88M | NYSE | |||
| 54.99 | 58.02 | 54.89 | -0.91 | -1.63% | 13.10M | NYSE | |||
| 29.38 | 30.19 | 29.38 | -0.04 | -0.14% | 192.67K | NYSE | |||
| 11.58 | 11.88 | 11.49 | +0.13 | +1.14% | 1.34M | NYSE | |||
| 59.75 | 63.12 | 59.68 | -1.05 | -1.73% | 10.05M | NASDAQ | |||
| 15.77 | 16.15 | 15.20 | +0.19 | +1.22% | 39.17M | NYSE | |||
| 3.37 | 3.77 | 1.82 | +1.52 | +82.16% | 31.46M | NASDAQ | |||
| 218.30 | 223.13 | 217.71 | -0.16 | -0.07% | 514.43K | NYSE | |||
| 215.11 | 220.88 | 214.89 | -0.67 | -0.31% | 703.07K | NYSE | |||
| 83.12 | 86.20 | 82.50 | -12.21 | -12.81% | 47.92M | NYSE |